• EMAIL
  • PRINT
  • PDF
  • Bookmark and Share

Education

  • J.D., Rutgers University School of Law - Newark, 1989
  • B.A., Ramapo College, 1985

Bar Admissions

  • New Jersey

Court Admissions

  • U.S. Court of Appeals, Third and Seventh Circuits
  • U.S. District Court, District of New Jersey

Memberships & Affiliations

American Bar Association, Section on Litigation

American Bar Association, Committee on Product Liability

American Bar Association, Women in Products Liability Sub-Committee

International Association of Defense Counsel

Defense Research Institute, Drug and Medical Device Sub-Committee

New Jersey State Bar Association, Section on Civil Trial Practice

Vice Chair, Ramapo College Foundation

Debra M. Perry

  • |
Partner
  • T: 973.639.2083
    F: 973.297.3935
    • Four Gateway Center
      100 Mulberry St.
      Newark, NJ 07102

Debra Perry advises regulated biological product, pharmaceutical, and medical device companies on legal and compliance issues during the development, marketing and distribution phases of their products. She provides strategic planning and risk management guidance regarding FDA submissions, conduct of clinical trials, enforcement issues, and post-approval promotional, marketing and labeling issues.

Debra also defends pharmaceutical and other manufacturers in mass tort product liability litigation at the trial and appellate levels in state and federal courts. She has significant experience representing multinational companies in prescription and OTC medication litigation, including atypical anti-psychotics, anti depressants, hormone products, narcotic analgesics, and diabetes drugs. She also defends multinational corporations against industrial product liability claims, and helps companies select, train, and manage defense counsel nationwide and abroad.

Debra develops and implements strategies to confront the complex issues that arise in these types of litigation, including multi-district issues, defense of medical monitoring claims, federal preemption, product identification and market share liability, punitive damages, exposure, epidemiological analysis of causation, and Daubert (and its state law equivalents) hearings on the admissibility of medical and scientific expert testimony, and the application of statutes of limitations.

Debra also handles complex guardianship and estate matters in the Superior Court of New Jersey, Chancery Division, Probate Part. She lectures and writes extensively about compliance and risk management and was recognized as a New Jersey Super Lawyer for 2005–2006, 2008-2010 and 2014.

Representative Matters

In re Alleged Mahwah Toxic Dump Site Litigation, Superior Court of New Jersey, Law Division, Bergen County, Master Docket No. L-489-08, Case No. 277
In re Risperdal/Seroquel/Zyprexa Litigation, Superior Court of New Jersey, Law Division, Middlesex County, Case No. 274

Speaking

11/16/12
ABA Section of Litigation Pharmaceutical and Medical Device Litigation CLE Workshop
11/08/12
Eighth Annual General Counsel Institute – National Association of Women Lawyers
1/20/12
ABA Section of Litigation Joint Committees' CLE Seminar
11/03/11
Seventh Annual General Counsel Institute - National Association of Women Lawyers

Publications

03/17/14
08/22/12
Nationwide Flux: Mensing’s Impact on State Tort Claim Pre-emption & Generic Pharmaceuticals
International Association of Defense Counsel Newsletter
2012
ABA State-By-State Survey of the Statutes of Limitation and Repose Applicable to Pharmaceutical and Medical Device Litigation - New Jersey, Delaware, and Pennsylvania Chapters
Products Liability Litigation Committee - Section of Litigation, American Bar Association
Spring 2011